In a radical departure from the way Big Law doles out the partnership prize, Gibson Dunn & Crutcher elected an administrator (a cost center!) to partnership. It’s either a game changer or a clever gimmick.

Generic abortion pill maker GenBioPro is ending a challenge to a restrictive Mississippi law on ending pregnancies, effectively closing a legal battle over access to the drug amid the continued fallout spurred by the Supreme Court’s overturning of Roe v. Wade.

Efforts to end the spread of HIV in the US are slowly recovering after the Covid-19 pandemic hindered a federal initiative to end the epidemic by 2030, public health officials and researchers said.

Sen. Mark Kelly relied on numbers to persuade key Democrats this summer, including pivotal negotiator Sen. Joe Manchin, to squeeze $4 billion more into the tax, health, and climate bill to address severe drought in the West.

A recent decision allowing entities tied to the Boy Scouts of America to be released from sexual abuse claims has reignited debate over a controversial bankruptcy tactic and raised the stakes of an upcoming appellate court ruling involving Purdue Pharma LP.

A jury verdict believed to be the first to find that genetic material of a living organism qualified as a trade secret may add to precedent in a little-explored area of intellectual property law.